Philogen SpA
MIL:PHIL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Philogen SpA
MIL:PHIL
|
IT |
|
Transense Technologies PLC
LSE:TRT
|
UK |
|
IG Design Group PLC
LSE:IGR
|
UK |
|
Silvercrest Metals Inc
TSX:SIL
|
CA |
|
Jericho Energy Ventures Inc
XTSX:JEV
|
CA |
|
Sugita Ace Co Ltd
TSE:7635
|
JP |
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
ID |
|
Costain Group PLC
LSE:COST
|
UK |
|
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
US |
|
Shimadzu Corp
TSE:7701
|
JP |
|
AAC Technologies Holdings Inc
HKEX:2018
|
CN |
|
Qudian Inc
NYSE:QD
|
CN |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
Kelsian Group Ltd
ASX:KLS
|
AU |
|
Centaur Media PLC
LSE:CAU
|
UK |
|
C
|
Cembre SpA
MIL:CMB
|
IT |
|
Tigers Polymer Corp
TSE:4231
|
JP |
Bankruptcy Probability
Philogen SpA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Philogen SpA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IT |
|
Philogen SpA
MIL:PHIL
|
663.7m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Philogen SpA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Philogen SpA has total debt of 10.3m EUR. This includes both short-term (0 EUR) and long-term (10.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
